HealthDay - THURSDAY, Nov. 12 (HealthDay News) — Declining use of hormone
replacement therapy may be driving down rates of a condition called
“atypical ductal hyperplasia,” a known risk factor for breast cancer, new
research suggests.

Źródło: http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/hsn/20091113/hl_hsn/lesshrtfewercasesofpossiblebreastcancerprecursor

Comments are closed